Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

13.76 -0.01 (-0.07%)
Streaming Delayed Price Updated: 9:58 AM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Earnings Scheduled For February 25, 2022 ↗
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •... 
Via Benzinga
News headline image
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25, 2022
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Appointment of Thomas A. West to Board of Directors
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical's Return on Invested Capital Overview ↗
Benzinga Pro data, Orthofix Medical (NASDAQ:OFIX) reported Q3 sales of $112.43 million. Earnings fell to a loss of $313.00 thousand, resulting in a 107.34% decrease from last... 
Via Benzinga
News headline image
Orthofix Medical inc (OFIX) Q3 2021 Earnings Call Transcript ↗
OFIX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To... 
Via Benzinga
News headline image
Orthofix Reports Third Quarter 2021 Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 5, 2021 ↗
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter. • Healthcare Trust (NYSE:HTA) is... 
Via Benzinga
News headline image
Orthofix Announces Participation in Upcoming Credit Suisse and Stifel Healthcare Conferences
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 5, 2021
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Provides Business Update
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Milestone − More Than 60,000 M6-C Artificial Cervical Discs Implanted Worldwide
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Appointment of Wayne Burris to Board of Directors
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical's Return on Invested Capital Insights ↗
According to Benzinga Pro, during Q2, Orthofix Medical (NASDAQ:OFIX) earned $4.27 million, a 246.33% increase from the preceding quarter. Orthofix Medical also posted a total of $... 
Via Benzinga
News headline image
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical inc (OFIX) Q2 2021 Earnings Call Transcript ↗
OFIX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook ↗
Orthofix Medical Inc (NASDAQ: OFIX) reported Q2 adjusted EPS $0.32, compared to an adjusted net loss of $(0.59) a year ago, beating the consensus of $0.11. Sales... 
Via Benzinga
News headline image
Orthofix Medical: Q2 Earnings Insights ↗
Shares of Orthofix Medical (NASDAQ:OFIX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 154.24% over the past year to... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
Orthofix Reports Second Quarter 2021 Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 6, 2021 ↗
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
News headline image
Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 6, 2021
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces US Launch and First Patient Implants with New fiberFUSE Strip – An Advanced Fiber Bone-Graft Solution Containing Cancellous Bone
From Orthofix Medical Inc.
Via Business Wire
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.